MediWound Expands its Global Leadership Team to Help Drive Company’s Future Growth
YAVNE, Israel, March 06, 2023 (GLOBE NEWSWIRE) -- MediWound Ltd. (NASDAQ: MDWD) (the “Company”), a fully integrated biopharmaceutical company focused on next-generation biotherapeutic solutions for tissue repair and regeneration, today announced the appointment of Barry Wolfenson as Executive Vice President of Strategy & Corporate Development. In this role, Mr. Wolfenson will be responsible for the Company’s global strategic plan, business development and initiatives to generate overall growth. MediWound also announced the appointment of Alicia Torrenova, as Vice President of European Operations.
- In this role, Mr. Wolfenson will be responsible for the Company’s global strategic plan, business development and initiatives to generate overall growth.
- “We are very pleased to welcome Barry and Alicia to the MediWound team.
- Both are seasoned veterans with over 20 years of relevant experience, including having held leadership roles in strategy planning, business and corporate development,” said Ofer Gonen, Chief Executive Officer of MediWound.
- Mr. Wolfenson said, “I am excited to join the MediWound management team and be part of its exciting journey.